Skip to main content
Beta Bionics, Inc. logo

Beta Bionics, Inc. — Investor Relations & Filings

Ticker · BBNX ISIN · US08659B1026 US Manufacturing
Filings indexed 191 across all filing types
Latest filing 2025-10-31 Regulatory Filings
Country US United States of America
Listing US BBNX

About Beta Bionics, Inc.

https://www.betabionics.com

Beta Bionics, Inc. is a commercial-stage medical technology company that designs, develops, and commercializes solutions for diabetes management. Its flagship product is the iLet Bionic Pancreas, a fully automated insulin delivery system. The iLet uses an adaptive, learning algorithm to autonomously determine and deliver 100% of insulin doses based on data from a compatible continuous glucose monitor (CGM), such as the Dexcom G7 or Abbott FreeStyle Libre 3 Plus. The system is designed for people aged six and older with type 1 diabetes, aiming to reduce the burden of management by eliminating the need for manual carb counting and insulin correction calculations.

Recent filings

Filing Released Lang Actions
Regulatory Filings 2025
Regulatory Filings
2025-10-31 English
Major Shareholding Notification 2025
Major Shareholding Notification
2025-10-30 English
10-Q
Interim / Quarterly Report 9M 2025
2025-10-28 English
FORM 8-K
Regulatory Filings
2025-10-28 English
Major Shareholding Notification 2025
Major Shareholding Notification
2025-10-18 English
Major Shareholding Notification 2025
Major Shareholding Notification
2025-10-16 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.